You are here

Astellas

Astellas puts the cork back in $350M Xork deal after Cartesian-Selecta merger

Fierce Biotech

Thu, 03/14/24 - 06:22 pm

Cartesian Therapeutics

Astellas-owned Xyphos offers more than $800M for Kelonia's in vivo delivery know-how

Fierce Biotech

Thu, 02/15/24 - 07:21 pm

Xyphos Biosciences

Pharma showed up for the big game

Axios

Mon, 02/12/24 - 10:27 am

pharma advertising

Astellas adds digital to its top management team

Pharmaphorum

Thu, 02/8/24 - 11:05 am

Astellas' sales expectations are up for Padcev, down for Veozah

Fierce Pharma

Mon, 02/5/24 - 11:02 pm

FDA declines to approve Astellas' gastric cancer drug

Reuters

Tue, 01/9/24 - 09:39 am

Astellas strikes $1.7bn SIRP drug deal with Elpiscience

Pharmaphorum

Tue, 01/2/24 - 09:56 am

Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer

Fierce Pharma

Tue, 12/19/23 - 10:26 am

FDA starts review of Padcev/Keytruda for bladder cancer

Pharmaphorum

Fri, 12/1/23 - 09:35 am

priority review

Astellas builds case for menopause drug fezolinetant

Pharmaphorum

Thu, 11/30/23 - 09:54 am

Xtandi cleared by FDA for earlier-stage prostate cancer

Pharmaphorum

Fri, 11/17/23 - 10:10 am

prostate cancer

Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff

Fierce Biotech

Thu, 11/16/23 - 11:45 am

Propella Therapeutics

prostate cancer

Astellas Sees Path Forward for Gene Therapy Despite Four Patient Deaths

BioSpace

Thu, 11/16/23 - 11:36 am

X-linked myotubular myopathy

Astellas’ Izervay reduces GA lesion growth in Phase III trial

Clinical Trials Arena

Mon, 11/6/23 - 09:51 am

geographic atrophy

age-related macular degeneration

clinical trials

A New Drug For Menopausal Hot Flashes, Veozah, Faces Access Challenges

Forbes

Tue, 10/24/23 - 07:49 pm

ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer

Fierce Pharma

Wed, 10/18/23 - 11:42 am

Astellas rolls out national Veozah campaign for treating menopause symptoms

Medical Marketing and Media

Mon, 10/9/23 - 10:04 am

Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study

BioSpace

Thu, 09/28/23 - 10:33 am

clinical trials

Duchenne Muscular Dystrophy

Astellas Withdrew Its Inflation Reduction Act Lawsuit—Will Other Companies Follow?

BioSpace

Wed, 09/27/23 - 11:09 pm

Inflation Reduction Act

Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo

BioSpace

Fri, 09/22/23 - 11:53 am

urothelial cancer

clinical trials

Pages